Anesthetic-Induced Neurotoxicity: Molecular Pathways and Genetic Risk Factors

麻醉引起的神经毒性:分子途径和遗传风险因素

基本信息

  • 批准号:
    10549751
  • 负责人:
  • 金额:
    $ 34.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

Some individuals undergoing anesthesia and surgery will experience anesthetic-induced neurotoxicity (AiN) attributable to volatile general anesthetic agents (VGAs). AiN after exposure to VGAs can present with different phenotypes, including acute neurodegeneration, delirium, lifelong cognitive impairment in children and accelerated or even de novo neurodegeneration in the aged. Despite controversial clinical trials, the FDA, in a far-reaching response to recent data, has issued a warning on the use of VGAs in pregnant women and young children. Furthermore, the American Society of Anesthesiologists' Perioperative Brain Health Initiative has raised awareness of AiN for the aged brain. As neither the pathophysiology of AiN nor its risk factors are understood, there are neither prophylactic nor therapeutic measures. Our underlying hypothesis is that heritable factors determine the threshold for AiN vulnerability while biological and environmental variables shape its phenotype. We propose to approach AiN with a pharmacogenomic strategy in the fruit fly Drosophila melanogaster. We will use the ND2360114 strain, which is a model of Leigh syndrome (a human neurodegenerative disease caused by mutation of NDUFS8, the mammalian ortholog of ND23). Exposure of ND2360114 flies to VGAs results in four striking phenotypes: (1) young flies are equally hypersensitive to the behavioral effects of isoflurane and sevoflurane (reproducing the human phenotype), (2) middle-aged flies incur significant mortality within 24 hours after waking up from isoflurane, (3) genetic and environmental manipulations profoundly modulate mortality, and (4) phenotypically normal ND2360114/+ flies become sensitized to AiN from isoflurane at an advanced age thereby. We will use ND2360114 flies as a sensitized model of AiN with rapid, unambiguous readout. To investigate the modulatory role of genetic background on AiN, we will use genome-wide association study (GWAS) analysis to identify nucleotide polymorphisms that modify AiN in ND2360114/+ flies. To determine the scope of heterozygous mutations that increase the risk of AiN, we will screen candidate mutants in mitochondrial metabolic pathways. To identify key metabolic regulators of AiN, we will use RNA-seq under experimental conditions that result in different mortality rates. These studies are significant because exposure to VGA affects millions of people of all ages every year and concerns of AiN are widespread. Complications from exposure to anesthesia and surgery have long-lasting consequences. Considering genetic background when assessing the individual risk of AiN is a step towards personalized medicine. Understanding its pathophysiology offers a path to informed prevention and treatment.
一些接受麻醉和手术的人会经历麻醉剂引起的神经毒性(Ain)。 可归因于挥发性全身麻醉剂(VGA)。暴露于VGA后的AIN可呈现不同的 表型,包括急性神经变性,神志不清,儿童终身认知障碍和 老年人神经退行性变加速甚至新发。尽管有争议的临床试验,FDA在 对最近的数据做出了深远的回应,对孕妇使用VGA发出了警告,并 年幼的孩子。此外,美国麻醉学家协会的围手术期大脑健康倡议 提高了人们对老年人大脑AIN的认识。因为无论是AIN的病理生理学还是其危险因素都不是 据了解,既没有预防措施,也没有治疗措施。 我们的基本假设是,可遗传因素决定了AIN脆弱性的门槛,而生物学因素 而环境变量决定了它的表型。我们建议用药物基因组学方法来处理AIN 果蝇在黑腹果蝇中的策略我们将使用ND2360114菌株,这是Leigh的模型 综合征(一种由NDUFS8突变引起的人类神经退行性疾病),NDUFS8是 ND23)。ND2360114果蝇暴露于VGA产生了四种显著的表型:(1)幼蝇 对异氟醚和七氟醚(复制人类表型)的行为影响过敏,(2) 中年果蝇在从异氟醚中醒来后24小时内显著死亡,(3)遗传和 环境操纵深刻地调节了死亡率,以及(4)表型正常的ND2360114/+果蝇 从而在高龄时从异氟醚中对AIN敏化。我们将使用ND2360114苍蝇作为 AIN的敏化模型,具有快速、明确的读数。为了研究基因的调节作用 背景关于AIN,我们将使用基因组范围关联研究(GWAS)分析来识别核苷酸 ND2360114/+果蝇中AIN基因的多态性。来确定杂合突变的范围 增加AIN的风险,我们将在线粒体代谢途径中筛选候选突变。要确定 AIN的关键代谢调节剂,我们将在实验条件下使用RNA-seq,导致不同的 死亡率。 这些研究意义重大,因为接触VGA每年会影响数百万各个年龄段的人,而且 对AIN的担忧是普遍的。暴露在麻醉和手术中的并发症是长期存在的 后果。在评估AIN个体风险时考虑遗传背景是迈向 个性化医疗。了解其病理生理学为知情的预防和治疗提供了一条途径。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Serial Anesthesia Array for the High-Throughput Investigation of Volatile Agents Using Drosophila melanogaster.
Mutations in Complex I of the Mitochondrial Electron-Transport Chain Sensitize the Fruit Fly (Drosophila melanogaster) to Ether and Non-Ether Volatile Anesthetics.
  • DOI:
    10.3390/ijms24031843
  • 发表时间:
    2023-01-17
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Borchardt, Luke A. A.;Scharenbrock, Amanda R. R.;Olufs, Zachariah P. G.;Wassarman, David A. A.;Perouansky, Misha
  • 通讯作者:
    Perouansky, Misha
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID WASSARMAN其他文献

DAVID WASSARMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID WASSARMAN', 18)}}的其他基金

A Fly Model of Traumatic Brain Injury
创伤性脑损伤的苍蝇模型
  • 批准号:
    9034777
  • 财政年份:
    2016
  • 资助金额:
    $ 34.99万
  • 项目类别:
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
  • 批准号:
    9018070
  • 财政年份:
    2014
  • 资助金额:
    $ 34.99万
  • 项目类别:
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
  • 批准号:
    9223746
  • 财政年份:
    2014
  • 资助金额:
    $ 34.99万
  • 项目类别:
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
  • 批准号:
    8688528
  • 财政年份:
    2014
  • 资助金额:
    $ 34.99万
  • 项目类别:
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
  • 批准号:
    8814288
  • 财政年份:
    2014
  • 资助金额:
    $ 34.99万
  • 项目类别:
Neuroprotective drugs for A-T
A-T 神经保护药物
  • 批准号:
    8616449
  • 财政年份:
    2013
  • 资助金额:
    $ 34.99万
  • 项目类别:
Neuroprotective drugs for A-T
A-T 神经保护药物
  • 批准号:
    8739687
  • 财政年份:
    2013
  • 资助金额:
    $ 34.99万
  • 项目类别:
Genetic Analysis of Ataxia-telangiectasia
共济失调毛细血管扩张症的遗传分析
  • 批准号:
    7537212
  • 财政年份:
    2007
  • 资助金额:
    $ 34.99万
  • 项目类别:
Genetic Analysis of Ataxia-telangiectasia
共济失调毛细血管扩张症的遗传分析
  • 批准号:
    7913120
  • 财政年份:
    2007
  • 资助金额:
    $ 34.99万
  • 项目类别:
Genetic Analysis of Ataxia-telangiectasia
共济失调毛细血管扩张症的遗传分析
  • 批准号:
    7738931
  • 财政年份:
    2007
  • 资助金额:
    $ 34.99万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了